Interconnection Consulting with headquarters in Vienna and Barcelona is an internationally operating company and offers industry- and companyspecific one-stop solutions. The company emphasises its industry competence which it proves every day by detailed market reports for more than 1000 customers in all regions of the world.
(more…)

The industry profiles from independent market analyst Datamonitor give a comprehensive overview of the analyzed industry in the particular country. So the industry profiles are an essential ressource for top-level data and analysis. The reports provide textual analysis of the industry’s recent performance and future prospects and incorporate in-depth five forces competitive environment analysis and scorecards. They also include detailed data on market size and textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

(more…)

Governments take to customer relationship management solutions to enhance constituent relations

Driven by the need to improve its management of constituent relationships, a new report from Datamonitor, “CRM and the Move to Constituent-Centric Government”, predicts that government spending on customer relationship management (CRM) technology solutions in the US, UK, Germany and France will grow from $2.9 billion in 2008 to $4.4 billion in 2013. In today’s commercially-oriented world, it has become a trend among public sector agencies to treat constituents as customers who expect top levels of service. (more…)

A new report by independent market analyst Datamonitor finds that consumers are having a greater number of soft drink occasions, with consumption projected to increase through 2011. Consumers in the UK had 2.3 soft drink occasions per person per day in 2006, and this is projected to grow quicker than for Europe as a whole and the US, to reach 2.9 occasions by 2011. Datamonitor’s report analyzes how consumers’ changing hot and soft drink preferences are shaping the non-alcoholic drinks industry.
 
(more…)

Anyone looking for well-founded studies about building products, healthcare, business services or environment quickly encounters the report provider MSI (Marketing Research for Industry). MSI is an independent market research company being active on several European markets (D, GB, FR, E). Known for its accurate and up-to-date market informations MSI fills niche markets with its studies.
(more…)

Commercial cards represent the fastest-growing segment of the Western European payment card market, according to a new report from independent market analyst Datamonitor. The value of transactions carried out on commercial payment cards in Western Europe reached EURO87.1 billion in 2006, and is forecast to grow to EURO180.3 billion in 2011.
(more…)

The ageing population and growing risk factors have made a significant impact on driving up the number of registered heart failure cases. Existing pharmacological strategies are improving the survival rates of acute and early-stage heart failure patients, ironically providing a growing body of patients with progression of the disease to heart failure. With no new drug therapies addressing advanced heart failure and existing pharmacological strategies failing to compensate for a weakening heart, alternative solutions have to be found. In view of long waiting lists for heart transplantation and the growing lack of donor hearts, significant numbers of patients die while waiting for a heart transplant. But cardiac resynchronization therapy, mechanical circulatory support devices and other alternative technologies have demonstrated promising results, and the continuing rapid technological developments in this area suggest we may only be a decade away from eliminating the reliance on heart transplantation, according to a new cardiologic report by independent market analyst Datamonitor.   
(more…)

Although the inhaled delivery of drugs has major advantages over other methods of administration, inhaler devices are often difficult to use and can indirectly have a negative impact on symptom control. Unfortunately, in a classic catch-22 situation, those devices that are developed to overcome the disadvantages of the majority of inhalers often lack broad availability across different therapeutic molecules and drug classes. Offering physicians and patients a range of therapies in the same type of device will therefore improve proper use of inhalers, which can indirectly have a positive impact on the control of diseases like asthma and chronic obstructive pulmonary disease (COPD), according to a new report by independent market analyst Datamonitor.
(more…)

Lung cancer is the leading cause of cancer-related mortality throughout much of the industrialized and developing world. Smoking is the main cause of lung cancer, but with smoking on the decline in most western societies, it seems we have seen the peak of the lung cancer incidence in the west. In Asia, however, a lung cancer epidemic is looming as more smokers die and more children take up smoking. Today though, lung cancer is still responsible for more deaths annually in Western countries than breast, colorectal and prostate cancers combined. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for about 80% of all cases, and despite recent advances in treatment, NSCLC remains a disease of poor prognosis, with few treatment options available and an overall five year survival rate of about 15%. According to a new report , despite extensive research and development (R&D) in the field, new drugs may struggle to improve NSCLC patient outcomes. However, research in the field of biomarkers may help improve the treatment of the disease, tailoring therapy to individual patient characteristics. (more…)

The increase in cost-limiting measures used by governments and a constant stream of patent expiries mean that the global generics market continues to grow. Generics sales growth is slowing in mature markets like the US, where generics use is high. However, as governments look to curb healthcare spending, the introduction of pro-generic legislation will see less mature markets, like Spain, change.
(more…)